Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
103,938,430
-
Share change
-
-1,982,541
-
Total reported value
-
$2,184,232,492
-
Put/Call ratio
-
430%
-
Price per share
-
$20.98
-
Number of holders
-
262
-
Value change
-
-$42,938,248
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2013
As of 31 Dec 2013,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,938,430 shares.
The largest 10 holders included
ROYCE & ASSOCIATES LLC, Capital Research Global Investors, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, Luxor Capital Group, LP, MUNDER CAPITAL MANAGEMENT, Sterling Capital Management LLC, FIR TREE INC., BlackRock Institutional Trust Company, N.A., and State Street Corp.
This page lists
262
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.